Skip to content

FFP3 Respirators and Ears - Effects on Middle Ear Pressure and Hearing

FFP3 Respirators and Ears - Effects on Middle Ear Pressure and Hearing

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05222230
Acronym
FFP3-RAE
Enrollment
12
Registered
2022-02-03
Start date
2022-07-23
Completion date
2022-12-31
Last updated
2022-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eustachian Tube Dysfunction, Hearing Disorders, Nasal Obstruction

Keywords

FFP3M respirators, eustachian tube dysfunction, hearing loss, audiometry, tympanometry

Brief summary

This is Prospective Basic Science Study whose aims are as follows: 1. To determine the effect of Filtering Facepiece (FFP3M) respirators on eustachian tube function and hearing 2. To evaluate the extent to which FFP3M respirators attenuate speech in decibels The outcome measures are as follows: 1. Changes in baseline pure tone audiometry and tympanometry post intervention. 2. SNOT-22 Questionnaires before and after use of respirator 3. ETDQ7 questionnaire 4. Measurement of speech attenuation in decibels.

Detailed description

The use of facemasks is one of the key strategies for reducing human to human transmission of SARS-CoV-2. There is a variety of facemasks worn in the clinical environment ranging from simple facemasks to devices such as filtering face piece 3M (FFP3M) respirators which are mandatory for some clinicians performing aerosol generating procedures (AGPs.) It has been shown that wearing face protective equipment attenuates sound causing decay in speech intelligibility, especially transmission of middle-to-high voice frequencies.It has been shown that wearing surgical masks results in up to 23.3% loss of speech intelligibility in noisy environments with advanced face personal protective equipment such as FFP3M devices, accounting for up to 69.0% reduction of speech intelligibility. A reduction in speech intelligibility leads to reduced understanding which may result in miscommunication thereby compromising patient safety. To date, there have been two critical incidents in our department due to miscommunication attributed to wearing FFP3M respirators. Anecdotally, clinicians have reported nasal congestion and subjective hearing loss during FFP3M respirator usage and after, especially when they are worn for a prolonged period of time. Clinicians working in theatre may be required to wear these devices for a number of hours when involved with AGPs. The secondary consequences of wearing FFP3M respirators for prolonged periods of time, especially in a theatre setting require scientific exploration. This study aims to investigate the effect of FFP3M respirators on middle ear pressure and hearing, and the extent to which FFP3M respirators attenuate sound. Investigators believe that a reduction in speech intelligibility is not the only explanation for the perception of hearing loss when using FFP3M respirators. Investigators postulate that a transient dysfunction in the eustachian tube pressure regulating system also contributes to hearing loss. To test this hypothesis, investigators will measure hearing and middle ear pressure using pure tone audiometry and tympanometry before and during FFP3M usage. Investigators will also use SNOT-22 and ETDQ7 questionnaires which are validated patient reported outcome measures for nasal symptoms and eustachian tube function. Investigators hope that this study provides some understanding of the physiological effects of FFP3M respirators on hearing and sinonasal symptoms and improves our understanding of their impact on clinical practice. There are no current studies looking into the effects of FFP3M respirators on eustachian tube function.

Interventions

OTHERFFP3 Mask

Participans will wear FFP3 respirators during the study.

Sponsors

Liverpool University Hospitals NHS Foundation Trust
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Prospective open label basic science study.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthcare workers that already have their own masks, fitted and provided by the Trust for day-to-day clinical use * Participants without pre-existing sinonasal symptoms or previous sinonasal surgery * Participants without pre-existing hearing loss or a history of otological procedures

Exclusion criteria

* Participants with pre-existing sinonasal symptoms or previous sinonasal surgery * Participants with pre-existing hearing loss or a history of otological procedures * Participants who do not satisfy the requirements set out in the pre-registration questionnaire

Design outcomes

Primary

MeasureTime frameDescription
Changes in baseline tympanometry post intervention48 hoursWe will measure changes in baseline tympanometry post FFP3 respirator usage.
Measurement of speech attenuation in decibels.1 hoursWe will measure speech attenuation in decibels when participants are wearing FFP3 respirators
Changes in baseline pure tone audiometry post intervention.48 hoursWe will measure changes in baseline pure tone audiometry post FFP3 respirator usage..

Secondary

MeasureTime frameDescription
Eustachian tube function48 hoursParticipants will complete the SINO-NASAL OUTCOME TEST (SNOT-22) Questionnaire which is a 22 point questionnaire. Participants will be asked to grade the severity of their symptoms from 1-5 with with higher scores denoting severe symptoms. The questionnaires will be completed pre and post interventions to investigate changes in eustachian tube function.

Contacts

Primary ContactNazia Munir, FRCS ORL-HNS
nazir.munir@liverpoolft.nhs.uk07970921448
Backup ContactTodd Kanzara, FRCS ORL-HNS
todd.kanzara@nhs.net07796945100

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026